Trametinib for a <i>BRAF G469A</i> missense mutation in a neuroblastoma unveiled by liquid biopsy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Trametinib for a BRAF G469A missense mutation in a neuroblastoma unveiled by liquid biopsy

Published:2022-06-02 Issue:11 Volume:69 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Toutain Gauthier¹,Min Victoria¹,Rome Angélique¹,Andre Nicolas¹²³^ORCID

Affiliation:

1. Department of Pediatric Oncology, La Timone University Hospital of Marseille APHM Marseille France

2. Centre d'Essais Précoces en Cancérologie de Marseille (CEPCM), CLIPP2 APHM Marseille France

3. SMARTc Unit CRCM Inserm 1068‐CNRS UMR 7258 Aix‐Marseille University Marseille France

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29742

Reference9 articles.

1. Durable Response to Dabrafenib Combined With Trametinib in a Patient With NSCLC Harboring a BRAF G469A Mutation

2. Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials

3. Targeting Alterations in the RAF–MEK Pathway

4. Non-p.V600E BRAF Mutations Are Common Using a More Sensitive and Broad Detection Tool

5. Pediatric Gliomas

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates on liquid biopsies in neuroblastoma for treatment response, relapse and recurrence assessment;Cancer Genetics;2024-11

2. Efficacy of trametinib in a metastatic urothelial carcinoma patient with a BRAF mutation;IJU Case Reports;2024-07-10

3. Response to Dabrafenib Plus Trametinib in a Patient With an Uncommon Activating BRAF Mutation: A First in Non–Small Cell Lung Cancer;Journal of the National Comprehensive Cancer Network;2024-04

4. Antineoplastics;Reactions Weekly;2023-06-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3